How big is the Adeno-Associated Virus CDMO Market?

The Adeno-Associated Virus CDMO Market size is expected to reach USD 0.57 billion in 2024 and grow at a CAGR of 20.86% to reach USD 1.40 billion by 2029. Read More

What is the current Adeno-Associated Virus CDMO Market size?

In 2024, the Adeno-Associated Virus CDMO Market size is expected to reach USD 0.57 billion. Read More

Who are the key players in Adeno-Associated Virus CDMO Market?

Thermo Fischer Scientific Inc., Creative Biogene, Catalent Inc., Charles River Laboratories International Inc. and Aldevron are the major companies operating in the Adeno-Associated Virus CDMO Market. Read More

Which is the fastest growing region in Adeno-Associated Virus CDMO Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Adeno-Associated Virus CDMO Market?

In 2024, the North America accounts for the largest market share in Adeno-Associated Virus CDMO Market. Read More

What years does this Adeno-Associated Virus CDMO Market cover, and what was the market size in 2023?

In 2023, the Adeno-Associated Virus CDMO Market size was estimated at USD 0.45 billion. The report covers the Adeno-Associated Virus CDMO Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Adeno-Associated Virus CDMO Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Adeno-Associated Virus (AAV) CDMO Companies

This report lists the top Adeno-Associated Virus (AAV) CDMO companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Adeno-Associated Virus (AAV) CDMO industry.